Format

Send to

Choose Destination
Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5384-9. doi: 10.1073/pnas.1007645108. Epub 2011 Mar 14.

High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells.

Author information

1
Department of Pathology and Johns Hopkins Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Abstract

Most human cancers are aneuploid and have chromosomal instability, which contrasts to the inability of human cells to normally tolerate aneuploidy. Noting that aneuploidy in human breast cancer correlates with increased expression levels of the Mps1 checkpoint gene, we investigated whether these high levels of Mps1 contribute to the ability of breast cancer cells to tolerate this aneuploidy. Reducing Mps1 levels in cultured human breast cancer cells by RNAi resulted in aberrant mitoses, induction of apoptosis, and decreased ability of human breast cancer cells to grow as xenografts in nude mice. Remarkably, breast cancer cells that survive reductions in levels of Mps1 have relatively less aneuploidy, as measured by copies of specific chromosomes, compared with cells that have constitutively high levels of Mps1. Thus, high levels of Mps1 in breast cancer cells likely contribute to these cells tolerating aneuploidy.

PMID:
21402910
PMCID:
PMC3069188
DOI:
10.1073/pnas.1007645108
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center